Clinical trials in Algorta

Innovative clinical trials focusing on early-stage Alzheimer's disease and mild cognitive impairment, evaluating novel therapeutic approaches for symptom improvement and disease management.

• Early AD Intervention
• Cognitive Function Assessment
• Disease Progression Monitoring

Studies include evaluation of new compounds targeting amyloid reduction and cognitive enhancement.

Advanced research examining cerebrospinal fluid treatments and their impact on cognitive function in patients with mild to moderate Alzheimer's dementia.

• Treatment Safety Assessment
• Clinical Response Measurement
• Therapeutic Efficacy Studies

Research focuses on developing safe and effective adjunctive therapies for cognitive enhancement.

Comprehensive studies utilizing Clinical Dementia Rating scales and specialized cognitive assessment tools to measure treatment effectiveness.

• Cognitive Performance Metrics
• Treatment Response Evaluation
• Long-term Efficacy Monitoring

Trials incorporate advanced measurement techniques to track cognitive changes over extended periods.